Tuberculosis (TB) abdomen represents a significant clinical manifestation of Mycobacterium tuberculosis infection, specifically involving the peritoneal cavity. This form of extrapulmonary TB often develops from a primary focus elsewhere in the body, most commonly the lungs, through hematogenous spread or lymphatic dissemination. Understanding the intricacies of abdominal TB is crucial for clinicians due to its diverse presentations, potential for misdiagnosis, and the necessity for prompt, targeted treatment to prevent severe complications.
Pathogenesis and Transmission Dynamics
The pathogenesis of TB abdomen typically begins with the ingestion of infected sputum or the hematogenous spread of bacilli from a primary pulmonary lesion. Once inside the gastrointestinal tract, the bacteria can invade the intestinal mucosa or reach the peritoneal cavity via the lymphatic system. The resulting infection triggers a granulomatous inflammatory response, which is the hallmark of tuberculosis. This complex interplay between the bacilli and the host immune system dictates the clinical spectrum, ranging from asymptomatic carriage to life-threatening peritonitis.
Clinical Presentations and Diagnostic Challenges
TB abdomen manifests in various forms, including tuberculous peritonitis, intestinal tuberculosis, and abdominal lymphadenopathy. Symptoms are often insidious and non-specific, leading to diagnostic delays. Patients frequently report chronic abdominal pain, unexplained weight loss, low-grade fever, night sweats, and abdominal distension. The overlap of these symptoms with other gastrointestinal diseases, such as malignancies or Crohn's disease, makes accurate diagnosis particularly challenging and underscores the need for a high index of suspicion.
Common Signs and Symptoms
Chronic abdominal pain, often diffuse or localized to the right lower quadrant
Significant, unintentional weight loss and anorexia
Persistent low-grade fever and night sweats
Abdominal distension and bloating due to ascites or adhesions
Altered bowel habits, including diarrhea or constipation
Diagnostic Approaches and Investigations
Establishing a definitive diagnosis of TB abdomen requires a multifaceted approach. Initial investigations typically include comprehensive blood tests, inflammatory markers like ESR and CRP, and imaging studies. Abdominal ultrasound, CT scans, and contrast studies are invaluable for identifying characteristic features such as ascites, omental caking, lymphadenopathy, and strictures. However, microbiological or histopathological confirmation remains the gold standard.
Key Diagnostic Procedures
Ascitic Fluid Analysis
Colonoscopy with Biopsy
Percutaneous Biopsy
Treatment Protocols and Management Strategies
The cornerstone of TB abdomen treatment is a prolonged course of multi-drug anti-tuberculosis therapy (ATT). Standard regimens, guided by national and international protocols, typically involve an initial intensive phase with rifampicin, isoniazid, pyrazinamide, and ethambutol, followed by a continuation phase with rifampicin and isoniazid. The duration of therapy is often extended for extrapulmonary TB, sometimes lasting 9 to 12 months, to ensure complete eradication and prevent relapse.
